Blend Labs, Inc. filings document the company’s digital banking origination business, operating results, governance, capital actions, and material corporate events. Form 8-K reports cover quarterly and annual financial results, supplemental Regulation FD materials, product and service disclosures, officer-transition matters, and board-authorized repurchases of Class A common stock.
Blend’s proxy materials describe annual meeting matters, board elections, executive compensation, stockholder voting procedures, and related governance disclosures. Recent filings also document completed corporate actions, including the sale of substantially all assets and liabilities of Title365 Company, Blend’s former title insurance business.
Blend Labs (BLND) Q2-25 10-Q highlights:
- Revenue rose 9.9% YoY to $31.5 m; software platform revenue grew 11.0% to $29.4 m, while services slipped 4.0% to $2.1 m.
- Gross margin expanded to 74.0% (vs. 70.9%), lifting gross profit to $23.3 m (+14.6%).
- Cost discipline: R&D -43%, Sales & Marketing -23%, offset by G&A +20%; total opex fell 16% to $27.9 m.
- Operating loss narrowed sharply to $(4.6) m from $(13.1) m; net loss attributable to common holders improved to $(11.0) m, or $(0.04)/share, vs. $(23.6) m, $(0.09).
- Six-month view: revenue +11% to $58.3 m; net loss cut 61% to $(25.7) m.
- Cash & equivalents $36.5 m; marketable securities $51.8 m, giving liquidity of $88.3 m. Operating cash flow turned positive at +$14.8 m (vs. -$6.3 m LY).
- Balance sheet: stockholders’ equity improves to $(22.6) m from $(56.4) m, helped by reclassifying the Title365 non-controlling interest to equity and lower deficit. Deferred revenue jumped to $32.7 m (from $19.2 m), signaling larger future delivery obligations.
- Capital structure: 260.1 m shares outstanding (Class A/B); 150k Series A preferred now carries $150.2 m redemption value, with $4.4 m quarterly accretion; warrant for 11.1 m Class A shares unexercised.
- Strategic actions: Title business classified as discontinued; Q2 discontinued loss $(3.0) m. Minority buy-out ended put option, removing $52 m mezzanine liability.
Outlook: Management stresses cost control and liquidity; no formal guidance provided.
Blend Labs (BLND) Q2-25 10-Q highlights:
- Revenue rose 9.9% YoY to $31.5 m; software platform revenue grew 11.0% to $29.4 m, while services slipped 4.0% to $2.1 m.
- Gross margin expanded to 74.0% (vs. 70.9%), lifting gross profit to $23.3 m (+14.6%).
- Cost discipline: R&D -43%, Sales & Marketing -23%, offset by G&A +20%; total opex fell 16% to $27.9 m.
- Operating loss narrowed sharply to $(4.6) m from $(13.1) m; net loss attributable to common holders improved to $(11.0) m, or $(0.04)/share, vs. $(23.6) m, $(0.09).
- Six-month view: revenue +11% to $58.3 m; net loss cut 61% to $(25.7) m.
- Cash & equivalents $36.5 m; marketable securities $51.8 m, giving liquidity of $88.3 m. Operating cash flow turned positive at +$14.8 m (vs. -$6.3 m LY).
- Balance sheet: stockholders’ equity improves to $(22.6) m from $(56.4) m, helped by reclassifying the Title365 non-controlling interest to equity and lower deficit. Deferred revenue jumped to $32.7 m (from $19.2 m), signaling larger future delivery obligations.
- Capital structure: 260.1 m shares outstanding (Class A/B); 150k Series A preferred now carries $150.2 m redemption value, with $4.4 m quarterly accretion; warrant for 11.1 m Class A shares unexercised.
- Strategic actions: Title business classified as discontinued; Q2 discontinued loss $(3.0) m. Minority buy-out ended put option, removing $52 m mezzanine liability.
Outlook: Management stresses cost control and liquidity; no formal guidance provided.
Blend Labs, Inc. (BLND) filed a Form 4 disclosing that Winnie Ling, the company’s Head of Legal and People, sold 4,000 Class A common shares on 10 July 2025 at $3.54 per share. The sale was executed under a Rule 10b5-1 trading plan adopted on 14 March 2025.
The transaction generated roughly $14,160 in proceeds and leaves Ling with 380,018 shares held directly. The divestiture equates to about 1 % of her post-transaction stake, indicating that she maintains a substantial ownership position.
Because the trade was pre-scheduled and represents a small fraction of the insider’s holdings, it is unlikely to have a material impact on Blend Labs’ share supply or signal a change in corporate outlook. Nevertheless, investors often monitor insider activity for sentiment cues, so continued trends in insider buying or selling could influence market perception.